Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix
- 1 April 2003
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 55 (5) , 1247-1253
- https://doi.org/10.1016/s0360-3016(02)04401-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Factors Predicting Response to Chemotherapy and Survival in Patients with Metastatic or Recurrent Squamous Cell Cervical Carcinoma: A Multivariate AnalysisGynecologic Oncology, 1995
- Paclitaxel: A Radiation Sensitizer of Human Cervical Cancer CellsGynecologic Oncology, 1995
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)International Journal of Radiation Oncology*Biology*Physics, 1995
- Recurrent carcinoma of the cervix exclusively in the paraaortic nodes following radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Extended-field radiation therapy in early-stage cervical carcinoma: Survival and complicationsGynecologic Oncology, 1991
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI Journal of the National Cancer Institute, 1990
- Outcome of recurrent cervical carcinoma following definitive irradiationGynecologic Oncology, 1989
- Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotherapy groupRadiotherapy and Oncology, 1988
- The significance of paraaortic node status in carcinoma of the cervix and endometriumGynecologic Oncology, 1986
- Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodesGynecologic Oncology, 1984